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Hypothalamic–Pituitary–Thyroid Axis Hormones
Stimulate Mitochondrial Function and Biogenesis
in Human Hair Follicles
Silvia Vidali1,9, Jana Knuever1,9,10, Johannes Lerchner2,11, Melanie Giesen3,11, Tama´s Bı´ro´4, Matthias Klinger5,
Barbara Kofler6, Wolfgang Funk7, Burkhard Poeggeler1,12 and Ralf Paus1,8
Thyroid hormones regulate mitochondrial function. As other hypothalamic–pituitary–thyroid (HPT) axis
hormones, i.e., thyrotropin-releasing hormone (TRH) and thyrotropin (TSH), are expressed in human hair
follicles (HFs) and regulate mitochondrial function in human epidermis, we investigated in organ-cultured human
scalp HFs whether TRH (30nM), TSH (10mUml 1), thyroxine (T4) (100nM), and triiodothyronine (T3) (100pM) alter
intrafollicular mitochondrial energy metabolism. All HPT-axis members increased gene and protein expression of
mitochondrial-encoded subunit 1 of cytochrome c oxidase (MTCO1), a subunit of respiratory chain complex IV,
mitochondrial transcription factor A (TFAM), and Porin. All hormones also stimulated intrafollicular complex I/IV
activity and mitochondrial biogenesis. The TSH effects on MTCO1, TFAM, and porin could be abolished by K1-70,
a TSH-receptor antagonist, suggesting a TSH receptor–mediated action. Notably, as measured by calorimetry, T3
and TSH increased follicular heat production, whereas T3/T4 and TRH stimulated ATP production in cultured HF
keratinocytes. HPT-axis hormones did not increase reactive oxygen species (ROS) production. Rather, T3 and T4
reduced ROS formation, and all tested HPT-axis hormones increased the transcription of ROS scavengers
(catalase, superoxide dismutase 2) in HF keratinocytes. Thus, mitochondrial biology, energy metabolism, and
redox state of human HFs are subject to profound (neuro-)endocrine regulation by HPT-axis hormones. The
neuroendocrine control of mitochondrial biology in a complex human mini-organ revealed here may be
therapeutically exploitable.
Journal of Investigative Dermatology (2014) 134, 33–42; doi:10.1038/jid.2013.286; published online 15 August 2013
INTRODUCTION
The hypothalamic–pituitary–thyroid (HPT) axis controls multi-
ple metabolic processes in vertebrate organisms (Bassett and
Williams, 2008; Costa-E-Sousa and Hollenberg, 2012),
including human skin (Paus, 2010, 2011; Slominski et al.,
2012). Stimulation of the pituitary gland by hypothalamus-
derived thyrotropin-releasing hormone (TRH) leads to
thyrotropin (TSH) secretion. TSH then stimulates the thyroid
gland to synthesize and secrete the thyroid hormones (THs),
thyroxine (T4), and triiodothyronine (T3) (Zoeller et al., 2007).
Circulating T4 is thought to largely act after deiodination
into T3 in peripheral organs, including human hair follicles
(HFs) (Kaplan et al., 1988; van Beek et al., 2008; Safer et al.,
2009).
Several elements of the HPT axis are expressed in human
skin in situ and/or some of its constituent cell populations
in vitro: cultured human dermal and HF fibroblasts transcribe
TRH (Slominski et al., 2002), whereas TSH mRNA and protein
are found in normal human epidermis (Bodo´ et al., 2010) and
TSH receptor (TSHR) transcripts and protein in human skin
and HF mesenchyme (Bodo´ et al., 2009; Cianfarani et al.,
2010). Both TRH and its receptor are expressed in the epithe-
lium of normal human scalp HFs (Ga´spa´r et al., 2010, 2011).
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Human skin may therefore possess a peripheral equivalent of
the central HPT axis (Slominski et al., 2002, Bodo´ et al., 2010;
Paus, 2010).
THs directly alter important human HF functions, e.g., they
prolong anagen, stimulate hair matrix keratinocyte proli-
feration and pigmentation, and modulate intrafollicular
keratin expression (van Beek et al., 2008). Although TSH
regulates the expression of selected keratins in human HFs
(Ramot et al., 2011), its functions in HF biology remain
unclear (Bodo´ et al., 2009; Paus, 2010). Although THs and
TSH do not significantly modulate new hair shaft forma-
tion in vitro (van Beek et al., 2008; Bodo´ et al., 2009), TRH
potently stimulates hair shaft production, HF pigment-
ation, anagen duration (Ga´spa´r et al., 2010, 2011), and
intrafollicular prolactin and prolactin-receptor expression
in situ (Langan et al., 2010).
THs greatly affect mitochondria (Harper and Seifert, 2008,
Weitzel and Iwen, 2003, 2011), whose activities control
human energy metabolism and homeostasis (Scheffler, 2008,
Portman, 2008; Kharlip and Cooper, 2009). Mitochondria
process glycolysis and fatty acid oxidation products to
generate ATP, contain enzymes critical for multiple bio-
synthetic processes, contribute to the amino-acid metabolism
and ion homeostasis, regulate cell death pathways by reactive
oxygen species (ROS) and Ca2þ signaling, and are involved
in aging, cancer, and the pathogenesis of an ever-increasing
list of human diseases (Birch-Machin, 2006; Scheffler, 2008;
Wallace and Fan, 2009; Larsson, 2010; Wallace, 2010).
Therefore, fully understanding the hormonal controls of
mitochondrial biology is of major biological and clinical
interest also in the context of skin biology.
However, mainstream mitochondrial research has largely
ignored human skin as a research model, even though it has
recently turned out to serve as a most instructive model system
for identifying novel, clinically relevant hormonal controls of
mitochondrial function and biogenesis: both TRH and TSH
are powerful neuroendocrine regulators of mitochondrial
biology in human epidermis (Poeggeler et al., 2010a;
Knuever et al., 2012). However, whether THs, TRH, and/or
TSH exert a similar function in human HFs is unknown, as
HF mitochondrial biology has remained almost completely
unexplored.
As hair growth is a highly energy-consuming process
(Kealey et al., 1994; Stenn and Paus, 2001), we hypo-
thesized that HPT-axis hormones may also regulate human
HF energy metabolism and mitochondrial function.
Therefore, we asked whether and how TRH, TSH, and THs
influence intrafollicular mitochondrial biology in the absence
of neural, vascular, and extrafollicular hormonal inputs in
serum-free organ culture of healthy human scalp HFs. Each
hormone was tested in a selected concentration that we had
previously documented to significantly alter defined human
HF biology parameters (see Supplementary Text S4 online).
The list of mitochondrial read-out parameters that we had
previously established for organ-cultured human epidermis
(Poeggeler et al., 2010a; Knuever et al., 2012) was further
extended, including porin expression as an additional indi-
cator of mitochondrial biogenesis (Feichtinger et al., 2011)
and calorimetry as an indicator of mitochondrial energy
metabolism–dependent heat production (Lerchner et al.,
2008a, b). Furthermore, in cultured human outer root sheath
(ORS) keratinocytes, ATP and ROS production and the
expression of important ROS scavenger enzymes (catalase,
superoxide dismutase 2 (SOD2)) were measured.
RESULTS
HPT-axis elements increase MTCO1 and TFAM protein
expression in situ, whereas T3/T4 stimulate MTCO1 and TFAM
transcription
Previously, we had shown that TSH upregulates MTCO1
(mitochondrial-encoded subunit 1 of cytochrome c oxidase)
gene and protein expression in human HFs (Bodo´ et al., 2009)
and human epidermis, where it also increases the expres-
sion of mitochondrial transcription factor A (TFAM) (Poeggeler
et al., 2010a). TFAM controls mtDNA synthesis (Maniura-
Weber et al., 2004; Scarpulla, 2008; Vin˜a et al., 2009;
Hallberg and Larsson, 2011), maintains and stabilizes
mtDNA (Larsson et al., 1998), and is thus indispensable for
a functional electron transport chain (Baris et al., 2011).
Therefore, we first assessed the impact of HPT-axis
hormones on MTCO1 and TFAM expression in human scalp
HFs. This showed that T3, T4, and TSH significantly increased
MTCO1 immunoreactivity (IR) in the proximal ORS in situ,
where TRH showed only a slight increase in IR (Figure 1a–f).
TH treatment also increased intrafollicular MTCO1 mRNA
transcription (Figure 1g). TFAM protein expression in situ
was also significantly increased after 24 hours of treatment
with TRH, TSH, and THs (Figure 2a–f); T3 and T4 also
stimulated TFAM mRNA expression (Figure 2g). MTCO1 and
TFAM-IR were analyzed in the hair matrix as well (Figures 1h
and 2h). Interestingly, although T3 significantly increased
MTCO1-IR (Figure 1h), the other HPT hormones neither
affected MTCO1 nor TFAM-IR (for further qPCR results, see
Supplementary Text S1 online, Supplementary Figure S1
online).
T3/T4, TRH, and TSH treatment increases mitochondrial
biogenesis
This raised the question whether HPT-axis hormones can
stimulate intrafollicular mitochondrial biogenesis, as we
have already shown for TSH and TRH in human epidermis
(Poeggeler et al., 2010a; Knuever et al., 2012). Transmission
electron microscopy showed that the number of ultrastruc-
turally detectable perinuclear mitochondria was upregulated
by all HPT-axis players in human ORS keratinocytes in situ
(Figure 3a–f). To confirm this, porin-IR was assessed. Porin
is located in the mitochondrial membrane, acts as a
channel that enables small-molecule diffusion, and is well
established as a marker for mitochondrial mass (Feichtinger
et al., 2011). Treatment for 24 hours with T3 and TRH
significantly increased ORS porin-IR in situ, whereas T4 and
TSH showed just a stimulatory trend (Figure 3g–l). As
porin-IR in the hair matrix was not significantly affected
(Figure 3m), all tested HPT-axis elements stimulate mito-
chondrial biogenesis in the HF epithelium, but preferentially
in the ORS.
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TSH increases MTCO1, TFAM, and porin protein expression via
the classical TSHR pathway
To examine the underlying mechanism of action for at
least one of these HPT-axis players, we investigated
whether TSH effects are exerted via TSHR-mediated sig-
naling. This is indeed the case, as the TSH-induced mitochon-
drial effects were completely abolished by adding a selective,
TSHR-blocking antibody (K1-70 0.1mM) (Sanders et al., 2010;
Evans et al., 2010) (Figure 4a–q)
Mitochondrial activity is enhanced by treatment with HPT-axis
hormones
We then asked whether final outputs of mitochondrial activity
are also enhanced, using follicular heat production as a
physical indicator of enhanced mitochondrial energy metabo-
lism. In contrast to glycolysis and glutaminolysis, intramito-
chondrial redox processes strongly contribute to the overall
heat production (Gnaiger and Kemp, 1990; Jastroch et al.,
2010). Therefore, changes in the measured heat rate indicate
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Figure 1. Mitochondrial-encoded subunit 1 of cytochrome c oxidase
(MTCO1) expression. Hair follicles (HFs) were treated with (a) vehicle,
(b) triiodothyronine (T3; 100 pM), (c) thyroxine (T4; (100 nM), (d) thyrotropin
(TSH; 10 mU ml1), or (e) thyrotropin-releasing hormone (TRH; 30 nM) for
24 hours and immunostained for MTCO1 (nuclear counterstain: hematoxylin)
and evaluated by quantitative immunohistomorphometry. DP, dermal papilla;
HM, hair matrix; ORS, outer root sheath. Bar¼ 100mm. MTCO1-IR
compared with vehicle, measured in the ORS (f) and HM (h). Treatment groups
were normalized to the vehicle arbitrarily set to 100. n¼6–11 HFs (two
subjects). (g) MTCO1 mRNA steady-state levels (qRT–PCR) in HFs treated
with T3 (100 pM) or T4 (100 nM) for 24 hours. Data from 15 HFs (1 subject).
Mean±SEM (one-way analysis of variance (ANOVA)), *Po0.05, **Po0.01,
***Po0.001.
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Figure 2. Mitochondrial transcription factor A (TFAM) expression. Hair
follicles (HFs) treated with (a) vehicle, (b) triiodothyronine (T3; 100 pM),
(c) thyroxine (T4; 100 nM), (d) thyrotropin (TSH; 10 mU ml
1), or
(e) thyrotropin-releasing hormone (TRH; 30 nM) for 24 hours and immuno-
stained for TFAM (nuclear counterstain: 40,6-diamidino-2-phenylindole (DAPI))
and evaluated by quantitative immunohistomorphometry. DP, dermal papilla;
HM, hair matrix; ORS, outer root sheath. Bar¼ 100mm. Increased IR compared
with vehicle (arbitrarily set to 100), measured in the ORS (f) and
HM (h). n¼5–10 HFs (two subjects). (g) TFAM mRNA mRNA steady-state
levels (qRT–PCR) in HFs treated with T3 (100 pM) or T4 (100 nM) for 24 hours.
n¼ 15 HFs (1 subject). Mean±SEM (one-way analysis of variance (ANOVA)),
**Po0.01, ***Po0.001.
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an increase/decrease of the electron transfer rate in the
mitochondrial chain (Gnaiger and Kemp, 1990). HF heat
production was assessed with a chip-calorimetry device
(Lerchner et al., 2008a, b), thus presenting a direct heat mea-
surement of an intact human (mini-)organ in vitro, which was
previously unreported to the best of our knowledge.
As shown in Figure 5, HF treatment with two representative
substances T3 (100 pM) and TSH (10 mU ml
1) resulted in a
significantly enhanced heat release compared with vehicle.
The corresponding heat rate of about 0.3mW per HF is in line
with previously reported data for metabolic flows of human
HFs (Kealy et al., 1994).
Furthermore, we performed classical biochemical enzyme
activity measurements of key components of the respiratory
chain. These showed that T3, T4, TSH, and TRH stimulate the
activity of both complex I and IV after 24 hours of treatment
(Figure 5d, e). These data are a sensitive indirect indicator of
mitochondrial chain efficiency (Ko¨hnke et al., 1997; Durand
et al., 2012; Kim et al., 2012). In addition, we measured ATP
production of ORS keratinocytes (Figure 5f). TRH-treated cells
showed a significantly increased ATP production after 5 hours,
whereas THs showed consistent results only after 24 hours.
Taken together, these data conclusively demonstrate that the
tested HPT-axis players stimulate mitochondrial activity within
normal human scalp HFs.
TRH, TSH, and TH treatment does not alter the redox state of
ORS keratinocytes
As increased mitochondrial activity can lead to enhanced
ROS production and consequently increased oxidation and
ROS-mediated cell damage (Gemma et al., 2007; Wallace,
2010; Vendelbo and Nair, 2011), enhancing mitochondrial
function is not necessarily a beneficial event. Therefore, we
checked ROS production in cultured ORS keratinocytes, using
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Figure 3. Mitochondrial biogenesis. Hair follicles (HFs) treated with (a, g) vehicle, (b, h) triiodothyronine (T3; 100 pM), (c, i) thyroxine (T4; 100 nM),
(d, j) thyrotropin (TSH; 10 mU ml 1), or (e, k) thyrotropin-releasing hormone (TRH; 30 nM) for 24 hours. (a–f) Number of ultrastructurally detectable mitochondria
(transmission electron microscopy, TEM), particularly in the perinuclear region of human ORS keratinocytes. n¼ 10–12 keratinocytes (six subjects). N, nucleus; red
arrows indicate exemplary mitochondria. Green bar¼ 5mm. (g–k) Porin-IR. DP, dermal papilla; HM, hair matrix; ORS, outer root sheath. Yellow bar¼ 100mm.
(l, m) Porin-IR was assessed by quantitative immunohistomorphometry. Data are reported as percentages, normalized to the vehicle. n¼ 5–10 HFs (2 subjects).
Mean±SEM (one-way analysis of variance (ANOVA)), *Po0.05, ***Po0.001.
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the ROS-sensitive CM-H2DCFDA probe (Eruslanov and
Kusmartsev, 2010). After 24 hours of treatment, ROS produc-
tion did not significantly differ in HF keratinocytes treated
with any of the HPT-axis hormones compared with vehicle.
THs rather seemed to exert a slightly (yet not significant)
ROS-protective effect after 10 minutes of H2O2 challenge:
although there was a moderately increased ROS production
in vehicle-, TRH-, and TSH-treated keratinocytes, this was
lacking in the TH-treated one (Figure 6a).
HPT-axis hormones upregulate the expression of
ROS-scavenging enzymes by human HF keratinocytes
Finally, the transcription of two crucial ROS-scavenging
enzymes, catalase and SOD2 (Chelikani et al., 2004; Silva
et al., 2005; Halliwell and Gutteridge, 2007; Vafaee et al.,
2010; Marionnet et al., 2011), was measured in cultured
human ORS keratinocytes, as human HFs express these
enzymes, whose activity likely affects HF aging and graying
(Slominski et al., 2005; Wood et al., 2009). Interestingly,
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catalase transcription was significantly upregulated by all
treated HPT-axis hormones. TSH and T4 also enhanced
SOD2 mRNA steady-state levels in ORS keratinocytes
(Figure 6b and c). These data raise the possibility that HPT-
axis players may even boost intrafollicular ROS-scavenging
systems.
DISCUSSION
The biochemical, gene expression, ultrastructural, immuno-
histomorphometric, and calorimetric data presented here
provide unequivocal evidence that the tested HPT-axis hor-
mones rapidly stimulate mitochondrial gene expression and
mitochondrial biogenesis within normal human scalp HFs.
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Moreover, TRH, TSH, and THs stimulate mitochondrial
activity. These findings are well in line with the long-
recognized stimulatory role of THs on mitochondrial biology
and with the recent discovery of TRH and TSH as neuro-
endocrine regulators of human epidermal mitochondrial
function in situ (Poeggeler et al., 2010a; Knuever et al.,
2012). Importantly, major mitochondrial stimulation was
exerted on ORS keratinocytes, and not in the hair matrix,
the germinative part of the HF epithelium. The ORS might thus
be viewed as the energy storage compartment of the HF,
perhaps to spare the germinative compartment from sources
of oxidative stress (for detailed discussion, see Supplementary
Text S2 online).
The fact that TSH action is completely abolished by
antagonizing TSHR signaling strongly suggests that TSH acts
on HF mitochondria via its receptor rather than via alternative
pathways. That TSH affects HF mitochondrial biology via
TSHR also correlates with the fact that TSHR, when bound by
its ligand, activates a cyclic adenosine monophosphate/PKA
cascade. This cascade not only promotes the release of THs
but also influences many other pathways, including mito-
chondrial function and biogenesis as well as apoptosis
(Antoni, 2012; Papa et al., 2002; Feliciello et al., 2005).
Therefore, it is conceivable that TSH affects human HF
mitochondrial biology mainly through cyclic adenosine
monophosphate release.
As the human epidermis expresses TSH mRNA and protein
(Bodo´ et al., 2010) and human skin also expresses TSHR
(Bodo´ et al., 2009, Cianfarani et al., 2010), we expected the
levels of TFAM, MTCO1, and porin to be modulated by the
TSHR antagonist alone. Instead, these remained unchanged
(Figure 4). This suggests that, in the absence of specific stimuli,
intrinsic production of TSH in human HFs is low and
dispensable for maintaining baseline TFAM, MTCO1, and
porin levels.
Given that increased mitochondrial protein expression does
not necessarily imply increased mitochondrial energy produc-
tion, the latter was investigated by chip calorimetry and
classical enzyme activity assays. These experiments clearly
demonstrate that both T3 and TSH enhance HF heat pro-
duction, although both hormones activate very distinct
signal transduction pathways. Furthermore, TRH, TSH, and
THs stimulate mitochondrial chain complex I and IV activity
in human HFs and slightly increase ATP production in
ORS keratinocytes, well in line with our previous findings in
the epidermis and brain tissue (Poeggeler et al., 2010a, b;
Knuever et al., 2012). As T3 already stimulates heat produc-
tion after only 2 hours and slightly increases ATP production
after 5 hours, its action on mitochondrial activity may not be
exerted via the classical nuclear receptor pathway. It remains
to be determined whether the observed T3 effects operate via
intramitochondrial receptor isoforms (e.g., p43) (Wrutniak
et al., 1995; Casas et al., 1999).
The current study represents a systematic characterization
of HF mitochondrial biology and encourages one to explore
the as under-investigated energy metabolism of human
HFs (Williams et al., 1993; Kealey et al., 1994). Our study
also underscores that, contrary to conventional wisdom in
mainstream mitochondrial research, not only human
epidermis (Birch-Machin, 2006; Poeggeler et al., 2010a;
Knuever et al., 2012) but also the metabolically highly
active HF offers excellent model systems for dissecting the
function, biogenesis, and controls of human mitochondria
in situ. Human HF chip calorimetry even permits to directly
measure heat production of a living human (mini-)organ
in vitro. Moreover, our data show that, besides THs, the
intrafollicularly produced neurohormones, TSH and TRH,
profoundly affect human HF energy metabolism.
Our findings underscore the importance of neuroendocrine
controls not only in general mitochondrial biology (Poeggeler
et al., 2010a, b; Knuever et al., 2012), but also in human skin
and HF biology (Slominski and Wortsman, 2000; Arck et al.,
2006; Slominski et al., 2002, 2007; Paus, 2010, 2011;
Zmijewski and Slominski, 2011). The lessons learned from
studying organ-cultured human HFs may well be transferrable
to other, less accessible human tissues.
The current data also provide clinically relevant pointers to
how HF aging and disease correlated with declining mito-
chondrial function might be effectively counteracted in the
future by endogenous neurohormones produced in the human
epithelium, e.g., TRH (Ga´spa´r et al., 2010) and TSH (Bodo´
et al., 2010). This also applies to THs, which have long been
known to modulate hair shaft quality and/or pigmentation
(Messenger, 2000; van Beek et al., 2008). Both TRH and T4
are administered routinely in thyroid medicine and are
FDA-approved agents with a well-known toxicity profile.
Therefore, regulatory hurdles to reposition these hormones
for novel ‘‘mitochondrial hair medicine’’ approaches are
relatively low.
Current ‘‘mitochondrial medicine’’ concepts (e.g., Wallace
et al., 2010; Wallace, 2011) assume that, in systems with
declining mitochondrial function, the therapeutic increase
of mitochondrial activity generally exerts beneficial effects.
However, increased mitochondrial activity could also have
undesirable sequelae, such as increased ROS production
(Gemma et al., 2007; Vendelbo and Nair, 2011). However,
our HF keratinocyte data suggest that HPT-axis hormones
stimulate HF mitochondria without increasing ROS formation
or affecting HF vitality (for details, Supplementary Text S3
online). These hormones may even promote intrafollicular
ROS scavenging by upregulating catalase and SOD2 transcrip-
tion. Evidently, only long-term stimulation experiments and
in-depth analyses of ROS production, ROS damage indi-
cators, and scavenging system efficiency can dissipate
remaining concerns that long-term administration of HPT-axis
hormones might tip the balance of desired toward adverse
mitochondrial effects. Such follow-up studies are needed to
inform future clinical applications of HPT-axis hormones in
general ‘‘mitochondrial medicine’’ and gerontobiology.
In summary, we show that mitochondrial function, energy
metabolism, and biogenesis of human HFs are all subject to
profound (neuro-)endocrine regulation by TRH, TSH, and
THs. This makes it even more pressing to further explore the
HPT-axis equivalent system of human skin and its appendages
(Paus, 2010; Slominski et al., 2002, 2012), and to explore how
this system can be therapeutically targeted.
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MATERIALS AND METHODS
Skin samples, human HF organ culture
Human scalp skin samples were obtained after written informed
consent and institutional research board ethics license (University of
Luebeck) from 14 healthy middle-aged women undergoing routine
cosmetic plastic surgery, adhering to Helsinki guidelines. The varying
numbers of HFs and subjects are stated in each figure legend.
HF organ culture was performed in serum-free Williams’ E medium
supplemented with glutamine, insulin, hydrocortisone, and an anti-
biotic/antimycotic mixture as described before (Philpott et al., 1990;
Bodo´ et al., 2009; Kloepper et al., 2010; Ga´spa´r et al., 2011). After
pre-culture of microdissected HFs for 24 hours to minimize
dissection-associated disturbances, vehicle, T3, T4, TRH, TSH
(Sigma-Aldrich, Schnelldorf, Germany), and/or the TSHR antagonist
K1-70 (RSR, Cardiff, UK) were added for an additional 24 hours.
After treatment, the HF samples were shock-frozen in liquid nitrogen
and stored at  80 1C. Sections (6mm thick) were obtained for
immunostainings. As very limited human HFs were available, one
carefully selected concentration was assessed for each hormone,
based on prior published results: T3 (100 pM), T4 (100 nM) (van Beek
et al., 2008), TRH (30 nM) (Ga´spa´r et al., 2010, 2011), and TSH
(10 mU ml 1) (Bodo´ et al., 2009; Poeggeler et al., 2010a). The
concentration of 0.1mg ml 1 K1-70 was chosen according to the
manufacturer’s protocols (Evans et al., 2010; Sanders et al., 2010)
(further details, Supplementary Text S4 online).
Human ORS keratinocyte culture
Human ORS keratinocyte cultures were obtained from face-lift
surgery samples of healthy donors. Primary cultures of ORS keratino-
cytes were established from plucked anagen HFs, as described
(Philpott and Kealey, 1994).
Immunohistochemistry, immunofluoresescence, and quantitative
immunohistomorphometry
MTCO1-IR was determined as previously described (Poeggeler et al.,
2010a, b; Knuever et al., 2012). TFAM- and porin-IR were investi-
gated by fluorescence microscopy. For the mitochondrial transcrip-
tion factor TFAM, a rabbit polyclonal antiserum (kindly provided by
Rudolf Wiesner, University of Cologne, Germany) was used (1:200,
O/N at þ 4 1C). As a secondary antibody, we used a goat anti-rabbit
Rhodamine (Jackson Immuno Research, Newmarket, Suffolk, UK)
(1:200, 2 hours at RT).
VDAC1/porin was used to depict mitochondrial biogenesis
(Feichtinger et al., 2011), using a rabbit polyclonal antibody (1:600,
O/N at þ 4 1C). As a secondary antibody, we used a goat anti-rabbit
biotinylated antibody (Jackson Immuno Research) (1:200, 45 minutes
at RT). The TSA method was used for detection (TSA kit, FITC, Perkin
Elmer, Rodgau, Germany). Omission of the primary antibody served
as negative control. Cell nuclei were demarcated by 40,6-diamidino-
2-phenylindole, and images were obtained by digital microscopy
(Keyence, Neu-Isenburg, Germany). Quantitative immunohisto-
morphometry was performed by assessing the relative intensity
of IR in precisely defined HF reference areas with ImageJ (NIH,
Bethesda, MD).
Transmission electron microscopy
Transmission electron microscopy was performed as previously
described (Kramer et al., 2005; Knuever et al., 2012). Briefly, after
2 hours of fixation with 2.5% glutaraldehyde, HFs were washed in
0.1 M cacodylate buffer, pH 7.2. Using 1% osmiumtetroxide, samples
were postfixed, dehydrated in ethanol, and embedded in araldite
(Fluka, Buchs, Switzerland). Ultrathin sections were stained with
uranyl acetate and lead citrate, and then viewed with an electron
microscope 400 (Philips, Hamburg, Germany).
Chip calorimetry
Heat measurements as a reliable indicator of follicular mitochondrial
activity/energy metabolism were performed using an innovative
prototype chip calorimeter (Lerchner et al., 2008a, b) (for methodol-
ogical details on Calorimetry and prototype chip functionality, see
Supplementary Text S5 online).
Quantitative real-time PCR (qRT–PCR)
Steady-state mRNA levels from organ-cultured human HFs were
studied by qRT–PCR after 24 hours of incubation with the HPT-axis
hormones for the following key genes of mitochondrial biogenesis
and/or energy metabolism: MTCO1, TFAM, heat-shock protein 60,
peroxisome proliferator–activated receptor gamma coactivator-
1alpha, and brain and muscle aryl hydrocarbon receptor nuclear
translocator-like protein 1 (Cappello et al., 2008; Jung-Hynes et al.,
2010; Safdar et al., 2011). Gene expression was assessed by quantita-
tive real-time PCR performed on an ABI PRISM 7000 Sequence
Detection System (Applied Biosystems, Life Technologies, Darmstadt,
Germany) according to the published protocol, and normalized to
one of three tested housekeeping genes that proved to be least
regulated by the test hormone (Knuever et al., 2012).
The qRT–PCR in ORS keratinocytes for SOD2 and catalase was
performed as previously described in Giesen et al., 2011 (further
details, Supplementary Text S1, S6 online).
Biochemical assays
Complex I and IV activity were analyzed in HF homogenates as
described by (Poeggeler et al., 2010a, b), according to the protocols
of Mazzio and Soliman, 2004, Dabbeni-Sala et al., 2001, and Rustin
et al., 1994. Both experiments were performed with eight HFs each
and were repeated multiple times, with HFs from six different
subjects.
ATP quantification was performed on ORS cells seeded in a black
96-well plate (25,000 cells per well) with fully supplemented medium
(Limat and Noser, 1986). After first 24 hours of incubation, treatments
were added for further 24 hours (substances dissolved in medium
without FCS, T3, and Ham F12). The ATP Assay was performed
according to the manufacturer’s instructions (ATPlite, Perkin Elmer).
ROS production in ORS keratinocytes
Production of ROS was detected fluorometrically using the specific
dye CM-H2DCFDA (Life Technologies) according to the manufac-
turer’s protocol (further details, Supplementary Text S7 online).
Statistical analysis
If not stated otherwise, all data were analyzed using one-way analysis
of variance (Tukey’s test) by using the Graph Pad Prism software
(Graph Pad Software, La Jolla, CA).
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